Ravichandiran Velayutham (Velayutham Ravichandiran)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 2

Top Topics

Mycobacterium Tuberculosis

Top Venues

Anti-inflammatory & anti-allergy agents in medicinal chemistry

Infectious disorders drug targets

This page only lists publications with an associated author ORCID identifier.

Publications

Karthikeyan Sundaram, Leela Kagithakara Vajravelu, Ravichandiran Velayutham, Utpal Mohan
Identification of Genes Encoded Toxin-Antitoxin System in Mycobacterium Tuberculosis Strains from Clinical Sample. Infectious disorders drug targets 24 (8) (2024)
Vinod Kumar Rajana, Sudha Madhavi Penumaka, Cevella Saritha, Ravichandiran Velayutham, Debabrata Mandal
Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar, Received FDA Approval for Treating Different Forms of Inflammatory Diseases. Anti-inflammatory & anti-allergy agents in medicinal chemistry (2023)